QuidelOrtho outlines $2.7B-$2.9B 2026 revenue target as company advances R&D pipeline and margin expansion
Source: SeekingAlpha
2026-02-11 22:05:04 ET
More on Quidel
- QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call Transcript
- QuidelOrtho: EBIT Margins In Focus As We Approach Q4 Earnings Release
- QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- QuidelOrtho Q4 results beat on both lines, but issues weak 2026 EPS guidance
- Quidel Non-GAAP EPS of $0.46 beats by $0.04, revenue of $724M beats by $23.91M
Read the full article on Seeking Alpha
For further details see:
QuidelOrtho outlines $2.7B–$2.9B 2026 revenue target as company advances R&D pipeline and margin expansion
QuidelOrtho Corp Com
NASDAQ: QDEL
QDEL Trading
-3.4% G/L:
$18.59 Last:
406,203 Volume:
$19.01 Open:
QDEL Latest News
February 18, 2026 04:05:00 pm
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
QDEL Stock Data
$2,010,094,269
67,252,225
0.28%
91
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
